New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

FDA Clears First COVID-19 Breath Test

Move over painful swabs, now we have a breathalyzer that identifies compounds associated with SARS-CoV-2 infections.

A recent CNN article contained good news for people who prefer not to have swabs inserted deep into their nostrils. The FDA has granted emergency use authorization for a COVID-19 breath test. The diagnostic tool identifies chemical compounds associated with the virus in breath, and can be used in medical offices and mobile testing sites. The test is called the InspectIR Covid-19 Breathalyzer, and it detects five compounds associated with SARS-CoV-2 infections. A study on the device found that it was able to accurately identify 91% of positive samples, and virtually 100% of negative samples. A video with more information can be seen here. Finally, a breathalyzer I wouldn’t mind taking!

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts